Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. It provides Avexitide, an investigational, first-in-class glucagon-like peptide-1, or...
17 insider purchases on record · latest filing 2026-05-26.
Insiders have also filed 126 sale transactions at AMLX.